SNMMI consensus statement on patient selection and appropriate use of (177)Lu-PSMA-617 radionuclide therapy Guidelines

  

Authors:	Hope, T. A.; Antonarakis, E. S.; Bodei, L.; Calais, J.; Iravani, A.; Jacene, H.; Koo, P. J.; Morgans, A. K.; Osborne, J. R.; Tagawa, S. T.; Taplin, M. E.; Sartor, O.; Morris, M. J.
Title:	SNMMI consensus statement on patient selection and appropriate use of (177)Lu-PSMA-617 radionuclide therapy
Keywords:	patient selection; prostate specific antigen; prostate-specific antigen; radioisotope; radioisotopes; castration resistant prostate cancer; dipeptides; single heterocyclic rings; heterocyclic compounds, 1-ring; lutetium; dipeptide; humans; human; male; prostatic neoplasms, castration-resistant; psma-617
Journal Title:	Journal of Nuclear Medicine
Volume:	64
Issue:	9
ISSN:	0161-5505
Publisher:	Society of Nuclear Medicine
Date Published:	2023-09-01
Start Page:	1417
End Page:	1423
Language:	English
DOI:	10.2967/jnumed.123.265952
PUBMED:	37290800
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85168879818&doi=10.2967%2fjnumed.123.265952&partnerID=40&md5=4cec2982968feff279280870c576dfb6
Notes:	Article -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/209909